Overview

A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Abusers

Status:
Completed
Trial end date:
2013-08-09
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine if oxycodone and naltrexone combination capsules (ALO-02) have the potential to be abused.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Collaborators:
INC Research
Syneos Health
Treatments:
Analgesics, Opioid
Naltrexone
Oxycodone